Landry CA, Blanter J, Ru M, Fasano J, et al. Results of a Phase Ib Study Investigating Durvalumab in Combination with Eribulin in Patients with HER2-negative Metastatic Breast Cancer and Recurrent Ovarian Cancer. Oncology 2023 Aug 18. doi: 10.1159/000533420.
PMID: 37598677